<DOC>
	<DOCNO>NCT00650156</DOCNO>
	<brief_summary>Pharmacokinetic Safety Study Adalimumab Chinese Subjects Mild Rheumatoid Arthritis</brief_summary>
	<brief_title>Pharmacokinetic Safety Study With Adalimumab Chinese Subjects With Mild Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Male Female age 18 year old . Mild RA . Body weight less 100 kg . Wheelchairbound bedridden . Joint surgery involve joint assess within study , within two month prior Screening visit . Intraarticular , intramuscular intravenous ( IV ) administration corticosteroid within 28 day prior Screening visit . Prior treatment TNF antagonist , include adalimumab . Positive tuberculin PPD 5 . Female subject pregnant breastfeeding . History HIV immunocompromised . History malignancy . Poorly control medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>